Skip to main content

Advertisement

Log in

Contribution of objectively measured grating acuity by sweep visually evoked potentials to the diagnosis of unexplained visual loss

  • Neurophthalmology
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To investigate the diagnostic contribution of grating visual acuity (GVA) measured by sweep pattern-reversal visually evoked potentials (SPRVEP) in unexplained visual loss (UVL).

Methods

This case-control study included adult patients under suspicion of UVL referred to SPRVEP and transient pattern-reversal visually evoked potentials (TPRVEP) testing. Optotype visual acuity (OVA) was measured by ETDRS 4-meter chart and GVA by SPRVEP. UVL patients were assigned into three distinctive categories, according to the presence of ocular disease, motivation, and electrophysiological evaluation, as follows: exaggerators, malingerers, and psychogenic. Healthy controls and patients with organic visual loss were also tested. Receiver operating characteristic (ROC) curve was constructed to evaluate the diagnostic performance of GVA and TPRVEP parameters.

Results

A total of 76 patients with UVL were analyzed: 60 (79.0%) exaggerators, 11 (14.4%) malingerers, and 5 (6.6%) psychogenic. Controls were 49 subjects evaluated for TPRVEP and 28 subjects for SPRVEP. There were 13 patients with organic visual loss enrolled. Mean difference between OVA and GVA was 1.19±0.67 (median=0.84; 95% CI: 1.04 to 1.34) in UVL and 0.14 ±0.09 (median= 0.14; 95% CI: 0.08 to 0.20) in organic visual loss. The area under the ROC curve (AUC) of GVA to distinguish UVL from healthy controls was 0.998 with a cutoff of 0.09 logMAR showing specificity of 100% and sensitivity of 96.0%.

Conclusions

GVA measured by SPRVEP had good diagnostic validity to discriminate patients with unexplained visual loss from healthy controls and patients with organic visual loss, demonstrating its contribution to the diagnosis of this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Thompson HS (1985) Functional visual loss. Am J Ophthalmol 100:209–213. https://doi.org/10.1016/S0002-9394(14)75008-1

    Article  CAS  PubMed  Google Scholar 

  2. Xu S, Meyer D, Yoser S, Mathews D, Elfervig JL (2001) Pattern visual evoked potential in the diagnosis of functional visual loss. Ophthalmology 108:76–80. https://doi.org/10.1016/S0161-6420(00)00478-4

    Article  CAS  PubMed  Google Scholar 

  3. Reid S, Wessely S, Crayford T, Hotopf M (2001) Medically unexplained symptoms in frequent attenders of secondary health care: retrospective cohort study. Br Med J 322:767–769. https://doi.org/10.1136/bmj.322.7289.767

    Article  CAS  Google Scholar 

  4. O’Leary ÉD, McNeillis B, Aybek S, Riordan-Eva P, David AS (2016) Medically unexplained visual loss in a specialist clinic: a retrospective case-control comparison. J Neurol Sci 361:272–276. https://doi.org/10.1016/j.jns.2015.12.045

    Article  PubMed  Google Scholar 

  5. Griffiths PG, Eddyshaw D (2004) Medically unexplained visual loss in adult patients. Eye 18:917–922. https://doi.org/10.1038/sj.eye.6701367

    Article  CAS  PubMed  Google Scholar 

  6. Lim SA, Siatkowski RM, Farris BK (2005) Functional visual loss in adults and children: patient characteristics, management, and outcomes. Ophthalmology 112:1821–1828. https://doi.org/10.1016/j.ophtha.2005.05.009

    Article  PubMed  Google Scholar 

  7. Scott JA, Egan RA (2003) Prevalence of organic neuro-ophthalmologic disease in patients with functional visual loss. Am J Ophthalmol 135:670–675. https://doi.org/10.1016/S0002-9394(02)02254-7

    Article  PubMed  Google Scholar 

  8. Kathol RG, Cox TA, Corbett JJ, Thompson HS (1983) functional visual loss: follow-up of 42 cases. Arch Ophthalmol 101:729–735. https://doi.org/10.1001/archopht.1983.01040010729005

    Article  CAS  PubMed  Google Scholar 

  9. Incesu AI, Sobaci G (2011) Malingering or simulation in ophthalmology-visual acuity. Int J Ophthalmol 4:558–566. https://doi.org/10.3980/j.issn.2222-3959.2011.05.19

    Article  PubMed  PubMed Central  Google Scholar 

  10. Dattilo M, Biousse V, Bruce BB, Newman NJ (2016) Functional and simulated visual loss. Handbook of Clinical Neurology. Elsevier B.V, In, pp 329–341. https://doi.org/10.1016/B978-0-12-801772-2.00029-1

    Book  Google Scholar 

  11. American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders (5th Ed.): DSM-5. American Psychiatric Association, Washington, DC

    Book  Google Scholar 

  12. Galli S, Tatu L, Bogousslavsky J, Aybek S (2017) Conversion, factitious disorder and malingering: a distinct pattern or a continuum? Front Neurol Neurosci 42:72–80. https://doi.org/10.1159/000475699

    Article  PubMed  Google Scholar 

  13. Dhanji S, Lawlor M (2017) Functional visual loss. Curr Opin Neurol 30:200–205. https://doi.org/10.1097/WCO.0000000000000423

    Article  PubMed  Google Scholar 

  14. Bruce BB, Newman NJ (2010) Functional visual loss. Neurol Clin 28:789–802. https://doi.org/10.1016/j.ncl.2010.03.012

    Article  PubMed  PubMed Central  Google Scholar 

  15. Pula J (2012) Functional vision loss. Curr Opin Ophthalmol 23:460–465. https://doi.org/10.1097/ICU.0b013e328358c6dc

    Article  PubMed  Google Scholar 

  16. Moore Q, Al-Zubidi N, Yalamanchili S, Lee AG (2012) Nonorganic visual loss in children. Int Ophthalmol Clin 52:107–123. https://doi.org/10.1097/IIO.0b013e31825a1201

    Article  PubMed  Google Scholar 

  17. Robson AG, Nilsson J, Li S, Jalali S, Fulton AB, Tormene AP, Holder GE, Brodie SE (2018) ISCEV guide to visual electrodiagnostic procedures. Doc Ophthalmol 136:1–26. https://doi.org/10.1007/s10633-017-9621-y

    Article  PubMed  PubMed Central  Google Scholar 

  18. Di Russo F, Pitzalis S, Spitoni G, Aprile T, Patria F, Spinelli D, Hillyard SA (2005) Identification of the neural sources of the pattern-reversal VEP. Neuroimage 24:874–886. https://doi.org/10.1016/j.neuroimage.2004.09.029

    Article  PubMed  Google Scholar 

  19. Creel DJ (2019) Visually evoked potentials. Handb Clin Neurol 160:501–522. https://doi.org/10.1016/B978-0-444-64032-1.00034-5

    Article  PubMed  Google Scholar 

  20. Halliday AM, McDonald WI, Mushin J (1972) Delayed visual evoked response in optic neuritis. Lancet 1:982–985. https://doi.org/10.1016/s0140-6736(72)91155-5

    Article  CAS  PubMed  Google Scholar 

  21. Kinney JA (1977) Transient visually evoked potential. J Opt Soc Am 67:1465–1474. https://doi.org/10.1364/JOSA.67.001465

    Article  CAS  PubMed  Google Scholar 

  22. McBain VA, Robson AG, Hogg CR, Holder GE (2007) Assessment of patients with suspected non-organic visual loss using pattern appearance visual evoked potentials. Graefes Arch Clin Exp Ophthalmol 245:502–510. https://doi.org/10.1007/s00417-006-0431-2

    Article  PubMed  Google Scholar 

  23. Soares TS, Sacai PY, Berezovsky A, Rocha DM, Watanabe SE, Salomão SR (2016)Pattern-reversal visual evoked potentials as a diagnostic tool for ocular malingering. Arq Bras Oftalmol 79:303–307. https://doi.org/10.5935/0004-2749.20160087

    Article  PubMed  Google Scholar 

  24. Bobak P, Khanna P, Goodwin J, Brigell M (1993) Pattern visual evoked potentials in cases of ambiguous acuity loss. Doc Ophthalmol 85:185–192. https://doi.org/10.1007/BF01371133

    Article  CAS  PubMed  Google Scholar 

  25. Nakamura A, Akio T, Matsuda E, Wakami Y (2001) Pattern visual evoked potentials in malingering. J Neuroophthalmol 21:42–45. https://doi.org/10.1097/00041327-200103000-00013

    Article  CAS  PubMed  Google Scholar 

  26. Wildberger H, Huber C (1980) Visual evoked potentials (VEP) in the evaluation of suspected simulation and aggravation. Klin Monatsbl Augenheilkd 176:704–707. https://doi.org/10.1055/s-2008-1057538

    Article  CAS  PubMed  Google Scholar 

  27. Jeon J, Oh S, Kyung S (2012) Assessment of visual disability using visual evoked potentials. BMC Ophthalmol 12:1–9. https://doi.org/10.1186/1471-2415-12-36

    Article  Google Scholar 

  28. Sun IT, Lee JJ, Huang HM, Kuo HK (2015) Pattern visual evoked potentials for identifying malingering. Doc Ophthalmol 130:221–229. https://doi.org/10.1007/s10633-015-9483-0

    Article  PubMed  Google Scholar 

  29. Tyler CW, Apkarian P, Levi DM, Nakayama K (1979) Rapid assessment of visual function: an electronic sweep technique for the pattern visual evoked potential. Investig Ophthalmol Vis Sci 18:703–713

    CAS  Google Scholar 

  30. Katsumi O, Mehta MC, Larson-Park EW, Skladzien CJ, Hirose T (1994) Pattern reversal visual evoked response and Snellen visual acuity. Graefes Arch Clin Exp Ophthalmol 232:272–278. https://doi.org/10.1007/BF00194476

    Article  CAS  PubMed  Google Scholar 

  31. Norcia AM, Tyler CW (1985) Infant VEP acuity measurements: analysis of individual differences and measurement error. Electroencephalogr Clin Neurophysiol 61:359–369. https://doi.org/10.1016/0013-4694(85)91026-0

    Article  CAS  PubMed  Google Scholar 

  32. Hamer RD, Norcia AM, Tyler CW, Hsu-Winges C (1989) The development of monocular and binocular VEP acuity. Vis Res 29:397–408. https://doi.org/10.1016/0042-6989(89)90004-7

    Article  CAS  PubMed  Google Scholar 

  33. Till C, Rovet JF, Koren G, Westall CA (2003) Assessment of visual functions following prenatal exposure to organic solvents. Neurotoxicology 24:725–731. https://doi.org/10.1016/S0161-813X(02)00212-7

    Article  CAS  PubMed  Google Scholar 

  34. Salomão SR, Ejzenbaum F, Berezovsky A, Sacai PY, Pereira JM (2008) Age norms for monocular grating acuity measured by sweep-VEP in the first three years of age. Arq Bras Oftalmol 71:475–479. https://doi.org/10.1590/S0004-27492008000400002

    Article  PubMed  Google Scholar 

  35. Bradfield YS, France TD, Verhoeve J, Gangnon RE (2007) Sweep visual evoked potential testing as a predictor of recognition acuity in albinism. Arch Ophthalmol 125:628–633. https://doi.org/10.1001/archopht.125.5.628

    Article  PubMed  Google Scholar 

  36. Dotto PF, Cavascan NN, Berezovsky A, Sacai PY, Rocha DM, Pereira JM, Salomão SR (2014) Sweep visually evoked potentials and visual findings in children with West syndrome. Eur J Paediatr Neurol 18:201–210. https://doi.org/10.1016/j.ejpn.2013.11.008

    Article  Google Scholar 

  37. Cavascan NN, Salomão SR, Sacai PY, Pereira JM, Salomão SR (2014) Contributing factors to VEP grating acuity deficit and inter-ocular acuity difference in children with cerebral visual impairment. Doc Ophthalmol 128:91–99. https://doi.org/10.1007/s10633-013-9423-9

    Article  PubMed  Google Scholar 

  38. Bourne RRA, Flaxman SR, Braithwaite T et al (2017) Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health 5:e888–e897. https://doi.org/10.1016/S2214-109X(17)30293-0

    Article  PubMed  Google Scholar 

  39. Dotto P d F, Berezovsky A, Sacai PY et al (2017)Gender-based normative values for pattern-reversal and flash visually evoked potentials under binocular and monocular stimulation in healthy adults. Doc Ophthalmol 135:53–67. https://doi.org/10.1007/s10633-017-9594-x

    Article  PubMed  Google Scholar 

  40. Holladay JT (1997) Proper method for calculating average visual acuity. J Refract Surg 13:388–391. https://doi.org/10.3928/1081-597X-19970701-16

    Article  CAS  PubMed  Google Scholar 

  41. Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M (2006) Visual acuities “hand motion” and “counting fingers” can be quantified with the Freiburg Visual Acuity Test. Investig Ophthalmol Vis Sci 47:1236–1240. https://doi.org/10.1167/iovs.05-0981

    Article  Google Scholar 

  42. Bonnan M, Valentino R, Debeugny S, Merle H, Fergé JL, Mehdaoui H, Cabre P (2018) Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders. J Neurol Neurosurg Psychiatry 89:346–351. https://doi.org/10.1136/jnnp-2017-316286

    Article  PubMed  Google Scholar 

  43. Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Mizota A, Tormene AP (2016) ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol 133:1–9. https://doi.org/10.1007/s10633-016-9553-y

    Article  PubMed  Google Scholar 

  44. American Clinical Neurophysiology Society (2006) Guideline 5: guidelines for standard electrode position nomenclature. J Clin Neurophysiol 23:107–110. https://doi.org/10.1097/00004691-200604000-00006

    Article  Google Scholar 

  45. Norcia AM, Tyler CW (1985) Spatial frequency sweep VEP: Visual acuity during the first year of life. Vis Res 25:1399–1408. https://doi.org/10.1016/0042-6989(85)90217-2

    Article  CAS  PubMed  Google Scholar 

  46. Steele M, Seiple WH, Carr RE, Klug R (1989) The clinical utility of visual-evoked potential acuity testing. Am J Ophthalmol 108:572–577. https://doi.org/10.1016/0002-9394(89)90436-4

    Article  CAS  PubMed  Google Scholar 

  47. Gundogan FC, Sobaci G, Bayer A (2007) Pattern visual evoked potentials in the assessment of visual acuity in malingering. Ophthalmology 114:2332–2337. https://doi.org/10.1016/j.ophtha.2007.04.026

    Article  PubMed  Google Scholar 

  48. Hamilton R, Bradnam MS, Dutton GN, Yan ALLC, Lavy TE, Livingstone I, Mackay AM, Mackinnon JR (2013) Sensitivity and specificity of the step VEP in suspected functional visual acuity loss. Doc Ophthalmol 126:99–104. https://doi.org/10.1007/s10633-012-9362-x

    Article  PubMed  Google Scholar 

  49. Arai M, Katsumi O, Paranhos FR, Lopes de Faria JM, Hirose T (1997) Comparison of Snellen acuity and objective assessment using the spatial frequency sweep PVER. Graefes Arch Clin Exp Ophthalmol 235:442–447. https://doi.org/10.1007/BF00947064

    Article  CAS  PubMed  Google Scholar 

  50. Ridder WH 3rd, Waite BS, Melton TF (2014) Comparing enfant and PowerDiva sweep visual evoked potential (sVEP) acuity estimates. Doc Ophthalmol 129:105–114. https://doi.org/10.1007/s10633-014-9457-7

    Article  PubMed  Google Scholar 

  51. Ridder WH 3rd (2019) A comparison of contrast sensitivity and sweep visual evoked potential (sVEP) acuity estimates in normal humans. Doc Ophthalmol 139:207–219. https://doi.org/10.1007/s10633-019-09712-8

    Article  PubMed  Google Scholar 

  52. Katsumi O, Arai M, Wajima R, Denno S, Hirose T (1996) Spatial frequency sweep pattern reversal VER acuity vs Snellen visual acuity: effect of optical defocus. Vis Res 36:903–909. https://doi.org/10.1016/0042-6989(95)00187-5

    Article  CAS  PubMed  Google Scholar 

  53. Wiener DE, Wellish K, Nelson JI, Kupersmith MJ (1985) Comparisons among snellen, psychophysical, and evoked potential visual acuity determinations. Am J Optom Physiol Optic 62:669–679. https://doi.org/10.1097/00006324-198510000-00002

    Article  CAS  Google Scholar 

  54. Kurtenbach A, Langrová H, Messias A, Zrenner E, Jägle H (2013) A comparison of the performance of three visual evoked potential-based methods to estimate visual acuity. Doc Ophthalmol 126:45–56. https://doi.org/10.1007/s10633-012-9359-5

    Article  PubMed  Google Scholar 

  55. Hou C, Good WV, Norcia AM (2018) Detection of amblyopia using sweep VEP vernier and grating acuity. Investig Ophthalmol Vis Sci 59:1435–1442. https://doi.org/10.1167/iovs.17-23021

    Article  Google Scholar 

  56. Li L, Su Y, Chen CZ, Feng C, Zheng HM, Xing YQ (2011) Sweep pattern visual evoked potential acuity in children during their periods of visual development. Ophthalmologica 226:220–227. https://doi.org/10.1159/000329866

    Article  PubMed  Google Scholar 

  57. Skalka HW (1980) Comparison of Snellen acuity, VER acuity, and Arden grating scores in macular and optic nerve diseases. Br J Ophthalmol 64:24–29. https://doi.org/10.1136/bjo.64.1.24

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Kupersmith MJ (1986) Visual evoked potential: enhancing its utility. Semin Neurol 6:217–230. https://doi.org/10.1055/s-2008-1041465

    Article  CAS  PubMed  Google Scholar 

  59. Drislane FW (2007) Visual Evoked Potentials. In: Blum AS, Rutkove SB (eds) The clinical neurophysiology primer. Humana Press, pp 461–473. https://doi.org/10.1007/978-1-59745-271-7_25

    Chapter  Google Scholar 

  60. Scheerlinck LM, Schellekens PA, Liem AT, Steijns D, Rv L (2016) Incidence, risk factors, and clinical characteristics of unexplained visual loss after intraocular silicone oil for macula-on retinal detachment. Retina 36:342–350. https://doi.org/10.1097/IAE.0000000000000711

    Article  PubMed  Google Scholar 

  61. Hamilton R, Bach M, Heinrich SP, Hoffmann MB, Odom JV, McCulloch DL, Thompson DA (2021) VEP estimation of visual acuity: a systematic review. Doc Ophthalmol 142:25–74. https://doi.org/10.1007/s10633-020-09770-3

    Article  PubMed  Google Scholar 

  62. Sokol S, Moskowitz A (1981) Effect of retinal blur on the peak latency of the pattern evoked potential. Vis Res 21:1279–1286. https://doi.org/10.1016/0042-6989(81)90232-7

    Article  CAS  PubMed  Google Scholar 

  63. Fagan JE Jr, Yolton RL (1985) Theoretical reliability of visual evoked response-based acuity determinations. Am J Optom Physiol Optic 62:95–99. https://doi.org/10.1097/00006324-198502000-00005

    Article  Google Scholar 

  64. Chen CS, Lee AW, Karagiannis A, Crompton JL, Selva D (2007) Practical clinical approaches to functional visual loss. J Clin Neurosci 14:1–7. https://doi.org/10.1016/j.jocn.2006.03.002

    Article  PubMed  Google Scholar 

  65. McDermott BE (2012) Psychological testing and the assessment of malingering. Psychiatr Clin North Am 35:855–876. https://doi.org/10.1016/j.psc.2012.08.006

    Article  PubMed  Google Scholar 

  66. Bush SS, Ruff RM, Tröster AI, Barth JT, Koffler SP, Pliskin NH, Reynolds CR, Silver CH (2005) Symptom validity assessment: practice issues and medical necessity: NAN Policy & Planning Committee. Arch Clin Neuropsychol 20:419–426. https://doi.org/10.1016/j.acn.2005.02.002

    Article  PubMed  Google Scholar 

  67. Mittenberg W, Patton C, Canyock EM, Condit DC (2002) Base rates of malingering and symptom exaggeration. J Clin Exp Neuropsychol 24:1094–1102. https://doi.org/10.1076/jcen.24.8.1094.8379

    Article  PubMed  Google Scholar 

Download references

Funding

This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES)- Finance Code 001.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Solange Rios Salomão.

Ethics declarations

Ethical approval

The retrospective chart review involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study as controls.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Souza Soares, T., Berezovsky, A., Sacai, P.Y. et al. Contribution of objectively measured grating acuity by sweep visually evoked potentials to the diagnosis of unexplained visual loss. Graefes Arch Clin Exp Ophthalmol 260, 1687–1699 (2022). https://doi.org/10.1007/s00417-021-05385-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-021-05385-9

Keywords

Navigation